- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Huons Global led South Korean consortium to produce Sputnik V Covid-19 vaccine
![Huons Global led South Korean consortium to produce Sputnik V Covid-19 vaccine Huons Global led South Korean consortium to produce Sputnik V Covid-19 vaccine](https://medicaldialogues.in/h-upload/2020/03/05/750x450_125236-coronavirus-18.webp)
The consortium includes three other local companies- Prestige BioPharma, Humedix and Boran Pharma - which will build a new production facility, Huons said in a statement.
New Delhi: South Korea's Huons Global Co Ltd said on Friday it will lead a consortium to produce 100 million doses of Russia's Sputnik V Covid-19 vaccine per month as Moscow ramps up production for supplies abroad.
The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia's sovereign wealth fund late last year to make more than 150 million doses of Sputnik V per year.
Huons said the consortium will begin producing sample batches in August and respond flexibly to supply demands from the Russian Direct Investment Fund (RDIF).
The consortium includes three other local companies - Prestige BioPharma, Humedix and Boran Pharma - which will build a new production facility, Huons said in a statement.
Shares in Huons Global jumped 29.8% to their daily limit on Friday morning trade, versus a flat wider market.
India's ambassador to Moscow on Friday said deliveries of Russia's Sputnik V coronavirus vaccine to India were expected to begin before the end of April, after Indian regulators approved the shot for use on Monday.
The European Medicines Agency (EMA) is conducting a rolling review of the Russian vaccine as many European countries seek to ramp up inoculation programmes that have been hampered by delivery delays.
Read also: Dr Reddys working on Sputnik V stability data on 2 to 8 C temperature range
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story